Todos Medical Ltd. (TOMDF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2022 | 7.69 Million USD | -37.08% |
| 2021 | 12.23 Million USD | 134.88% |
| 2020 | 5.2 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2022 Q4 | 1.4 Million USD | -26.7% |
| 2022 Q2 | 2.17 Million USD | -0.91% |
| 2022 FY | 7.69 Million USD | -37.08% |
| 2022 Q1 | 2.19 Million USD | -50.66% |
| 2022 Q3 | 1.91 Million USD | -12.16% |
| 2021 Q1 | 5.03 Million USD | 29.3% |
| 2021 FY | 12.23 Million USD | 134.88% |
| 2021 Q4 | 4.45 Million USD | 341.29% |
| 2021 Q3 | 1.01 Million USD | -41.69% |
| 2021 Q2 | 1.73 Million USD | -65.57% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 5.2 Million USD | 0.0% |
| 2020 Q4 | 3.89 Million USD | 203.04% |
| 2020 Q3 | 1.28 Million USD | 3912.5% |
| 2020 Q2 | 32 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -742.826% |
| Arrayit Corporation | 4.37 Million USD | -75.793% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | 70.241% |
| Bioqual, Inc. | 58.59 Million USD | 86.867% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | 49.693% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 99.896% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | -20.872% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -631.749% |
| Interpace Biosciences, Inc. | 40.21 Million USD | 80.865% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -1619.557% |
| InVitro International | 792.62 Thousand USD | -870.821% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | 30.869% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | -6.517% |
| NovelStem International Corp. | 12 Thousand USD | -64025.0% |
| Optigenex Inc. | 465.97 Thousand USD | -1551.394% |
| PharmChem, Inc. | 6.01 Million USD | -27.985% |
| Proteome Sciences plc | 6.4 Million USD | -20.222% |
| Response Genetics, Inc | 18.04 Million USD | 57.345% |
| Rennova Health, Inc. | 13.03 Million USD | 40.972% |
| RushNet, Inc. | 1.78 Million USD | -330.398% |
| ScreenPro Security Inc. | 1.91 Million USD | -302.016% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | -102.763% |